HCID 178490812, compound → 1-(4-methoxy-benzyl)-3-(5-morpholin-4-ylmethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-ylamine
Reaction equation
[CH3:1][O:2][C:3]1[CH:33]=[CH:32][C:6]([CH2:7][N:8]2[CH:12]=[C:11]([N+:13]([O-])=O)[C:10]([C:16]3[NH:20][C:19]4[CH:21]=[CH:22][C:23]([CH2:25][N:26]5[CH2:31][CH2:30][O:29][CH2:28][CH2:27]5)=[CH:24][C:18]=4[N:17]=3)=[N:9]2)=[CH:5][CH:4]=1>[Fe].O1CCOCC1.O>[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([CH2:7][N:8]2[CH:12]=[C:11]([NH2:13])[C:10]([C:16]3[NH:20][C:19]4[CH:21]=[CH:22][C:23]([CH2:25][N:26]5[CH2:27][CH2:28][O:29][CH2:30][CH2:31]5)=[CH:24][C:18]=4[N:17]=3)=[N:9]2)=[CH:32][CH:33]=1Participants
4
Procedure
To a mixture of 2-[1-(4-methoxy-benzyl)-4-nitro-1H-pyrazol-3-yl]-5-morpholin-4-ylmethyl-1H-benzimidazole (1.6 g, 3.57 mmol), Fe powder (2 g, 35 mmol) and FeSO4.7H2O (0.496 g, 1.78 mmol) was added 1,4-dioxane:water (5:1, 120 ml). The mixture was refluxed for 3 h, filtered through celite, washing with MeOH, and reduced in vacuo azeotroping with toluene. EtOAc (100 ml) was added and insoluble material removed via filtration. The filtrate was reduced in vacuo to give 1-(4-methoxy-benzyl)-3-(5-morpholin-4-ylmethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-ylamine as a dark brown solid (1.4 g, 94%). (LC/MS: Rt 1.72, [M+H]+ 419).
Workup
- temperatureThe mixture was refluxed for 3 h
- filtrationfiltered through celite
- washwashing with MeOH
- customazeotroping with toluene
- additionEtOAc (100 ml) was added
- custominsoluble material removed via filtration
Sources & evidence
- ORD record
- ord-c6d5152f62214381bbbf74b67466ee33
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07977477B2
Reaction notes
Loading…